|
ES405913A3
|
|
Procedure for the preparation of derivatives of alcohilxantina basically substituted. (Machine-translation by Google Translate, not legally binding)
|
|
ES401839A3
|
|
Procedure for the preparation of derivatives of alcohilxantina basically substituted. (Machine-translation by Google Translate, not legally binding)
|
|
DE1182624B
|
|
Procedure for activating myrosinase
|
|
DE1182776B
|
|
Process for increasing the solubility of theophylline
|
|
US3029239A
|
|
Basic substituted 1-and 7-alkylxanthines or salts thereof
|
|
US3046275A
|
|
N-substituted 2-phenyl-7-aminoalkoxy chromones
|
|
DE1095991B
|
|
Process for the preparation of a stable and injectable solution containing 1,2-dithia-cyclopentane-3-valeric acid
|
|
DE1119868B
|
|
Process for the preparation of basic substituted alkylxanthine derivatives
|
|
US3065234A
|
|
Preparation of 1-(beta-hydroxypropyl)-theobromine
|
|
DE1093951B
|
|
Procedure for the extraction of drugs containing proazulene
|
|
DE1095988B
|
|
Process for making a durable drug product
|
|
DE1123329B
|
|
Process for the preparation of basic substituted alkylxanthine derivatives.
|
|
DE1095990B
|
|
Process for the production of water-soluble preparations and concentrated, stable aqueous solutions of digoxin
|
|
DE1095285B
|
|
Process for the preparation of basic substituted alkylxanthine derivatives
|
|
DE1154899B
|
|
Process for increasing the solubility of purines and purine derivatives
|
|
DE1151096B
|
|
Process for the production of stable, concentrated aqueous solutions of oxyalkylated theophylline or oxyalkylated theobromine compounds
|
|
CA614205A
|
|
Digoxin-substituted xanthine preparations
|
|
CA685260A
|
|
7-theophylline derivatives and process for their manufacture
|
|
CA655481A
|
|
N-substituted 2-phenyl-7-aminoalkoxy chromones and a process for preparing them
|
